Originally published In Press as doi:10.1074/jbc.M200713200 on April 8, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21514-21521, June 14, 2002
The Kinetic Mechanism of Myo1e (Human Myosin-IC)*
Mohammed El
Mezgueldi
§,
Nanyun
Tang
,
Steven S.
Rosenfeld¶, and
E. Michael
Ostap
From the
Department of Physiology and The
Pennsylvania Muscle Institute, University of Pennsylvania School of
Medicine, Philadelphia, Pennsylvania 19104-6085 and the
¶ Department of Neurology, University of Alabama,
Birmingham, Alabama 35294
Received for publication, January 23, 2002, and in revised form, April 5, 2002
 |
ABSTRACT |
Myo1e is the widely expressed subclass-1
member of the myosin-I family. We performed a kinetic analysis of a
truncated myo1e that consists of the motor and the single IQ motif with
a bound calmodulin. We determined the rates and equilibrium constants for the key steps in the ATPase cycle. The maximum actin activated ATPase rate (Vmax) and the actin concentration
at half-maximum of Vmax
(KATPase) of myo1e are similar to those of the
native protein. The KATPase is low (~1
µM), however the affinity of myo1e for actin in the
presence of ATP is very weak. A weak actin affinity and a rapid rate of
phosphate release result in a pathway under in vitro assay
conditions in which phosphate is released while myo1e is dissociated
from actin. Actin activation of the ATPase activity and the low
KATPase are the result of actin activation of
ADP release. We propose that myo1e is tuned to function in regions of
high concentrations of cross-linked actin filaments. Additionally, we
found that ADP release from actomyo1e is > 10-fold faster than
other vertebrate myosin-I isoforms. We propose that subclass-1
myosin-Is are tuned for rapid sliding, whereas subclass-2 isoforms are
tuned for tension maintenance or stress sensing.
 |
INTRODUCTION |
Myosin-I motors are the single-headed, low molecular
weight, membrane-associated members of the myosin superfamily (1). The
molecular details of myosin-I function in the cell are not known, but
myosin-Is are thought to play important roles in cortical membrane
tension (2), endocytosis and endocytic trafficking (3-6), signal
transduction (7), and membrane ruffling (6, 8).
Myosin-Is are the most diverse of the unconventional myosins and
are represented by at least two phylogenetically distinct subclasses
based on sequence comparison of motor domains (9). Subclass-1 myosin-I
isoforms have long tails that contain lipid binding (TH1), proline-rich
(TH2), and Src homology-3 (TH3) domains. Subclass-1 isoforms were first
discovered in lower eukaryotes (10) and are sometimes termed
"amoeboid" isoforms. However, vertebrate members of this subclass
have been identified (11, 12). Subclass-2 myosin-I isoforms have short
tails that contain only TH1 domains and are also widely expressed
(9).
The kinetic mechanisms of all characterized myosin-Is follow the same
pathway with the same biochemical intermediates (13-16). However,
considerable kinetic variability exists within the myosin-I family. Key
rate constants of isoforms from lower eukaryotes are significantly
faster (3-10-fold) than those of the vertebrate isoforms. The
characterized lower eukaryote isoforms belong to subclass-1 (13), and
the characterized vertebrate isoforms are members of subclass-2
(14-16), thus suggesting the possibility that kinetic properties
correlate with the isoform subclass rather than with the specific
organism. Measurement of the rate constants of a vertebrate subclass-1
isoform will help determine whether kinetic properties are conserved
within the subclasses. Additionally, knowing the rate constants of the
different isoforms allows us to understand the physical limitations and
properties of myosin-I isoforms and thus provides insight into the
cellular functions of the subclasses. Comparisons of the sequences of
myosin-I subclasses may also help unravel the structural modifications
required for kinetic tuning of all myosin motors.
Myo1e, also known as myr-3 (12) and human myosin-IC (11), is the
subclass-1 myosin-I expressed in nearly all vertebrate cells.
Localization studies show that myo1e is found in regions of high actin
concentration (17, 18), and steady-state biochemical investigations
suggest that myo1e is capable of cross-linking actin filaments via an
ATP-insensitive actin binding site in its tail (19). This cross-linking
results in triphasic actin activated ATPase activity. Unlike myosin-Is
from lower eukaryotes, the ATPase activity of myo1e appears to be
regulated allosterically by its tail domain (19), and the ATPase
activity is not predicted to be regulated by heavy chain
phosphorylation by p21-activated kinase homologs (20). We measured all
of the key rate constants in the myo1e ATPase pathway and found that,
like subclass-1 isoforms from lower eukaryotes, the rate constants are
significantly faster than the characterized vertebrate subclass-2
isoforms, thus suggesting conservation of kinetics and function within
a single subclass across phylogenetic boundaries. However, we also
found differences in the myo1e kinetics which may tune the motor for
function in regions of high actin concentration.
 |
EXPERIMENTAL PROCEDURES |
Reagents, Proteins, and
Buffers--
N-Methyanthraniloyl
(mant)1 nucleotide
derivatives were purchased from Molecular Probes, and 2'-deoxymantATP
(dmantATP) was synthesized as described by Hiratsuka (21). ADP and ATP
concentrations were determined spectrophotometrically before each
experiment by absorbance at 259 nm,
259 = 15,400 M
1 cm
1. MantATP and mantADP
concentrations were determined by absorbance at 255 nm,
255 = 23,300 M
1
cm
1 (21).
Rabbit skeletal muscle actin was prepared and gel filtered (22). Actin
concentrations were determined by absorbance at 290 nm,
259 = 26,600 M
1
cm
1 (23). Actin was labeled with pyrenyl iodoacetamide
(pyrene-actin) and gel filtered (24). All actin was stabilized with a
molar equivalent of phalloidin (Sigma). Calmodulin (CaM) was expressed in bacteria and purified as described (25).
Steady-state and transient experiments were performed at 25 ± 0.1 °C in KMg50 buffer (10 mM imidazole, pH 7.0, 50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT (26-28)) or KMg0 buffer (10 mM imidazole, pH 7.0, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT). Free CaM (1-3
µM) was included in all solutions.
Myosin-I Expression and Purification--
The cDNA for human
myosin-IC (accession NM 004998), kindly provided by W. M. Bement
(University of Wisconsin), was truncated at Glu720,
generating a construct containing the motor domain and the only IQ
motif (referred to as myo1eIQ throughout the paper). A FLAG
peptide sequence was inserted at the C terminus and subcloned into the
baculovirus transfer vector pVL1392 (Invitrogen). Recombinant
baculovirus was generated using standard procedures.
Myo1eIQ with bound calmodulin was purified from
Sf9 cells that were coinfected with virus containing
recombinant myo1eIQ and CaM (Fig.
1). Four liters of log phase cells
(2 × 106 cells/ml) were infected and incubated at
27 °C for 60 h with shaking. Cells were harvested by
centrifugation; suspended in lysis buffer (10 mM Tris, pH
7.0, 200 mM NaCl, 2 mM MgCl2, 5 mM DTT, 1 mM phenylmethylsulfonyl fluoride,
0.01 mg/ml aprotinin, 0.01 mg/ml leupeptin), 2 mM MgATP,
and 0.05% Igepal at 4 °C; and homogenized with five strokes in a
Dounce homogenizer. Cell extract was centrifuged at 100,000 × g for 1 h. The supernatant was loaded onto anti-FLAG
antibody columns (Sigma). Columns were washed with 5 column volumes of
lysis buffer + 2 mM MgATP and 5 column volumes of lysis
buffer. Myo1eIQ was eluted with 10 mM Tris, pH
8.0, 100 mM NaCl, 1 mM DTT, 5 µM
CaM, 0.2 mg/ml FLAG peptide (Sigma), 0.01 mg/ml aprotinin, 0.01 mg/ml
leupeptin. Eluted protein was loaded directly on to an 8-ml Mono Q
column (Amersham Biosciences) equilibrated in column buffer (10 mM Tris, pH 8.0, 25 mM KCl, 1 mM
DTT) and eluted with a linear 25 mM-1 M KCl
gradient. The Mono Q column separated myo1eIQ from FLAG
peptide, ADP, ATP, and free CaM. Fractions containing myo1eIQ were dialyzed versus storage buffer (10 mM Tris, pH 7.5, 100 mM KCl, 1 mM
EGTA, 1 mM DTT, 50% glycerol), which concentrated the
protein and allowed for storage at
20 °C. Quantitative
densitometry showed that myo1eIQ was >95% pure, and the
CaM:myo1eIQ ratio was 1:1. Approximately 2 mg of pure myo1e
protein was obtained from 4 liters of cells.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Purification of myo1eIQ.
Coomassie-stained SDS-polyacrylamide gel showing purified
myo1eIQ. The associated light chain is CaM. Quantitative
densitometry shows that the CaM:heavy chain stoichiometry was 1:1. The
predicted molecular mass of the heavy chain from the amino acid
sequence is 83 kDa.
|
|
Steady-state ATPase Activity and Sedimentation
Assays--
Steady-state ATPase activities were measured in KMg50 or
KMg0 buffer at 25 °C using the NADH-coupled assay as described (27). Steady-state binding of 0.2 µM myo1eIQ to
0-50 µM actin was measured in KMg50 and KMg0 at 25 °C
in the presence of 2 mM MgATP by ultracentrifugation assays
(350,000 × g for 20 min). The fraction of actin-bound
myosin was determined by assaying the NH4/EDTA ATPase
activity of the supernatant (29).
Stopped Flow, Quenched Flow, and Kinetic Modeling--
Transient
kinetic measurements were made at 25 °C with an Applied Photophysics
(Surrey, UK) SX.18MV stopped flow having a 1.2-ms dead time. Tryptophan
fluorescence (
ex = 295 nm) was measured using a 320 nm
WG long pass emission filter (Oriel). A 400 nm long pass filter (Oriel)
was used to monitor pyrene (
ex = 365 nm), and mantADP
and mantATP (
ex = 295 nm) fluorescence. Usually three to
five transients were averaged before nonlinear least square fitting.
The time courses presented in the figures show the average of one to
four individual traces. Transients were fitted to exponential functions
using the software supplied with the stopped flow. Transient
Pi release was measured using the coupled assay system
containing the fluorescently labeled mutant of the phosphate-binding
protein (PiBP (30, 31)) with the stopped flow in sequential
mixing mode using an excitation wavelength of 425 nm and a 440 nm long
pass filter. The dead time of the instrument in this configuration was
~2 ms. Quenched flow measurements were performed with a KinTek (State
College, PA) RQF-3 apparatus. Errors reported are standard errors in
the fits.
Kinetic modeling and simulations were performed using
Scheme 1 of the actomyosin ATPase, where A is actin and M is myosin. Computer simulations were performed with KSIM (Neil C. Miller) or
Berkeley-Madonna (Robert I. Macey and George F. Oster; University of
California, Berkeley).
 |
RESULTS |
Steady-state ATPase and Actin Binding Parameters--
The ATPase
activities of subclass-1 myosin-I isoforms from all lower eukaryotes
are activated by phosphorylation of serine or threonine at the TEDS
site in an actin binding, surface loop by proteins that have homology
to p21-activated kinases (20). Although myo1e has serines immediately
adjacent to the TEDS site, it is not predicted to be regulated by heavy
chain phosphorylation (20). We were unable to phosphorylate
myo1eIQ with Pak3 or Acanthamoeba myosin-I heavy
chain kinase (not shown), thus confirming the TEDS rule (20).
The steady-state ATPase activity of myo1eIQ is activated
~2-fold by actin filaments. Steady-state (Fig.
2) and single turnover measurements (not
shown) gave rates of ~0.6 s
1 in the absence of actin
(Table I) in KMg50. The actin
concentration at half-maximum of the steady-state ATPase rate
(KATPase) is 1.2 ± 0.36 µM,
and the maximum ATPase rate (Vmax) at saturating
actin is 1.2 ± 0.03 s
1. The triphasic ATPase
activity observed with native myo1e was not observed (19).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Steady-state ATPase and actin binding
activity of myo1eIQ. The actin concentration
dependence of the steady-state turnover of 50 nM
myo1eIQ in KMg0 ( ) and KMg50 ( ) was measured using
the NADH-coupled assay. The data points represent acquisitions from
three different preparations, and the solid lines are best
fits to rectangular hyperbolas. The fraction of myo1eIQ
bound to actin in KMg0 ( ) in 2 mM ATP was measured by
cosedimentation.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Steady-state ATPase parameters for myo1eIQ
Conditions were 1 mM MgCl2, 1 mM EGTA,
1 mM DTT, 2 mM MgATP, 10 mM
imidazole, pH 7.0, 25 °C.
|
|
Steady-state actin binding measurements show that
myo1eIQ is dissociated predominantly from 0-50
µM actin in KMg0 (Fig. 2) and KMg50 (not shown) in the
presence of 2 mM MgATP. Therefore, in the presence of ATP,
the predominant steady-state myo1eIQ intermediates have a
very weak affinity for actin with an equilibrium dissociation constant
(Kd) greater than 50 µM.
Myo1eIQ Binding to Actin Filaments--
An ~80%
fluorescence quenching upon strong binding of myo1eIQ to
pyrene-actin allowed us to monitor the association of
myo1eIQ with actin in the absence (Reaction 1) and
presence (Reaction 2) of MgADP. Data were modeled as
and
where A* represents the unquenched fluorescent state of
pyrene-actin. Time courses of myo1eIQ and
myo1eIQ-ADP binding to pyrene-actin follow single
exponentials rates that depend linearly on the actin concentration
(Fig. 3A). The apparent second
order rate constant for myo1eIQ binding to actin obtained
from the slope is k
7 = 9.0 ± 0.7 µM
1 s
1 (Table
II). The apparent second order rate
constant for myo1eIQ-ADP binding to actin is
k
11 = 1.2 µM
1
s
1 (Table II).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Kinetics of myo1eIQ association
with actin filaments. A, concentration dependence of
the observed rate (kobs) of pyrene-actin binding
to 0.2 µM myo1eIQ in the absence ( ) and
presence ( ) of 1 mM MgADP in KMg50. Solids
lines are linear fits to the data. B, time course of
pyrene-actin fluorescence increase after mixing 0.4 µM
pyrene-actomyo1eIQ with 50 µM actin in the
absence (upper curve) and presence (lower curve)
of 1 mM MgADP. Smooth lines are the best fits of
the data to single exponentials.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Rate and equilibrium constants for the myo1eIQ ATPase cycle
KMg50 (50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 10 mM imidazole,
(pH 7.0, 25 °C).
|
|
The rate of dissociation of myo1eIQ and
myo1eI-ADP from pyrene-actin was measured by competition
with 60-fold excess of unlabeled actin (Fig. 3B). Time
courses fit single exponentials with rates k+7 = 0.056 s
1 and k+11 = 0.065 s
1 (Table II). Dissociation equilibrium constants
(K7 and K11) calculated from the dissociation and association rates
(k+7/k
7 and
k+11/k
11) are
K7 = 6.2 nM and
K11 = 55 nM (Table II).
MantATP Binding to Myo1eIQ and
Actomyo1eIQ--
We used the enhancement in fluorescence
of the ATP analog mantATP to measure the rate of nucleotide binding.
Unlike skeletal muscle myosin-II (32), an intrinsic tryptophan
fluorescence change upon MgATP binding was not detected. The transient
increase in mantATP fluorescence was best fit to two exponentials (data not shown). The two exponentials are not the result of the presence of
multiple mantATP isomers (33) because a two exponential fluorescence increase was also detected when experiments were performed with dmantATP, which is a single-isomer preparation of mantATP. The amplitude of the fast exponential phase is 70-80% of the signal, and
its rate is linearly related to the dmantATP concentration (Fig.
4A). We assumed a two-step ATP
binding reaction,

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
dmantATP binding to myo1eIQ and
actomyo1eIQ. A, rate of dmantATP binding to
0.5 µM myo1eIQ and B, dmantATP
binding to 0.5 µM actomyo1eIQ as a function
of nucleotide concentration. The observed rates
(kobs) were obtained by fitting the stopped flow
fluorescence data at each nucleotide concentration to the sum of two
exponentials. Apparent second order association rate constants were
determined from the slopes of the linear fits of the fast phase of the
two exponential fits (solid lines). The insets
show the nucleotide dependence of the slow phase of the two exponential
fits.
|
|
where K1 is a rapid equilibrium and
k+2 is a rate-limiting isomerization to the high
fluorescence state of dmantATP (ATP*). The apparent second order rate
constant for dmantATP binding, given by the slope of the plot of
the observed rate versus nucleotide concentration, is
K1k2 = 11 ± 0.4 µM
1 s
1 (Fig. 4A).
Fits of the slow exponential phase yielded an apparent second order
rate constant 0.65 µM
1 s
1
(Fig. 4A, inset). It was proposed for skeletal
muscle subfragment-1 that this slow rate reports the conformational
change that accompanies ATP hydrolysis (k3,
Scheme 1 (33)).
A two-exponential fluorescence increase was also observed in the
presence of actin. The amplitude of the fast exponential phase is
40-60% of the signal, and its rate is linearly related to the
nucleotide concentration with an apparent second order rate constant of
K1'k2' = 3.7 ± 0.3 µM
1 s
1 (Fig.
4B). The linear fit of the rates does not pass through the
origin. The apparent second order rate constant determined from the
slow exponential phase is 0.15 µM
1
s
1 (Fig. 4B, inset).
ATP-induced Population of the Weakly Bound
States--
Pyrene-actin fluorescence was used to monitor the
ATP-induced population of the weakly bound states (13, 34). Mixing ATP with pyrene-actomyo1eIQ resulted in an increase in
fluorescence (Fig. 5A,
upper trace in inset). Fluorescence transients
were best fit to single exponentials at all ATP concentrations
examined, and the rate of the fluorescence increase was hyperbolically
related to the ATP concentration (Fig. 5A). The mechanism of
ATP-induced fluorescence enhancement was modeled as shown in Reaction
4,

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
MgATP-induced population of weakly bound
actomyo1eIQ states. ATP-induced dissociation of 0.25 µM actomyo1eIQ monitored by pyrene-actin
fluorescence ( ) and light scattering ( ). A, the ATP
concentration dependence of kobs is shown for
the full range of ATP concentrations. All stopped flow transients fit
single exponentials. Pyrene fluorescence (solid line) and
light scattering (dashed line) data are fit to rectangular
hyperbolas. The inset shows pyrene fluorescence
(top) and light scattering (bottom) transients
obtained by mixing 0.25 µM actomyo1eIQ with
100 µM ATP fit to single exponential functions
(smooth lines). B, expanded graph shows that
kobs is linearly related to the ATP
concentration up to 70 µM ATP and that linear fits of the
data pass through the origin.
|
|
where K1' is a rapid equilibrium,
k2' is a rate-limiting isomerization to the high
fluorescence A*M·ATP state, and k+9 is the
dissociation rate. The maximum rate is k2' = 440 ± 9.0 s
1 and K1' = 397 ± 23 µM (Table II). The association rate
constant for MgATP binding to actomyo1eIQ obtained from the
initial slope (K1'k2') is
0.86 ± 0.11 µM
1s
1 (Fig.
5B) with a y intercept of zero.
Light scattering measurements were used to monitor the rate of
actomyo1eIQ dissociation by MgATP (Fig. 5A).
This measurement is different from the pyrene-actin measurements in
that pyrene-actin fluorescence reports the population of the attached
and detached M·ATP states (Scheme 1). Mixing MgATP with
actomyo1eIQ resulted in a rapid decrease in light
scattering (Fig. 5A, lower trace in
inset). The time courses follow single exponentials with rates that depend hyperbolically on the MgATP concentration (Fig. 5A). Fits to Reaction 4 yielded rate constants
(K1' = 334 ± 46 µM;
k+2' = 439 ± 23 s
1) nearly
identical to those obtained with pyrene-actin (Table II). Therefore,
the maximum rate of dissociation (k+9) upon ATP
binding is limited by k+2' (Reaction 4).
ATP Hydrolysis--
The rate of ATP hydrolysis in the absence of
actin (k+3 + k
3; Scheme
1) was measured directly by quenched flow (Fig.
6). There is a rapid initial burst of ATP
hydrolysis which fits a single exponential with a rate of 108 ± 14 s
1 at 50 µM MgATP. The rate of ATP
binding under experimental conditions is expected to be >500
s
1 (Table II), so this measurement is not limited by the
rate of nucleotide association. The presence of a phosphate burst
indicates that the rate-limiting step occurs after ATP hydrolysis. The
amplitude of the phosphate burst is 0.55 Pi/myosin (Fig.
6). If we assume that B = K3/(1 + K3) and K3 = (k+3/k
3), then
K3 = 1.2, k+3 = 59 s
1, and k
3 = 49 s
1
(Table II).

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 6.
Phosphate burst of myo1eIQ.
Time course of ADP·Pi formation by 2.0 µM
myo1eIQ in the absence of actin measured by quenched flow
after mixing with 50 µM ATP. The smooth line
is the best fit of the data to a single exponential
(kobs = 108 s 1).
|
|
Phosphate Release--
Fluorescently labeled PiBP was
used to measure directly the rate of phosphate release
(k+4 and k+4') in
sequential mix, single turnover, stopped flow experiments (Fig.
7A (30)). Apyrase-treated
myo1eIQ (2 µM) was mixed with 1 µM ATP, aged for 400 ms to allow for ATP binding, and
mixed with 0-40 µM actin (Fig. 7B).
PiBP was included with the myo1eIQ and the
actin to prevent transients resulting from phosphate released during
the age time or phosphate contamination in the actin.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Rate of Pi release from
myo1eIQ. A, time course of transient
Pi release from myo1eIQ after mixing with ATP
in a sequential mix, single turnover experiment in KMg50. The
smooth curve is a single exponential fit to the data. The
inset is an expanded region of the transient showing the
absence of a lag phase. B, actin concentration dependence on
the rate of phosphate release measured in KMg0 ( ) and KMg50 ( ).
Delay time after first mix was 400 ms. Final concentrations at
t = 0 were 1.0 µM myo1eIQ,
0.5 µM ATP, 5.0 µM PiBP, 0-40
µM actin.
|
|
The time course of phosphate release in the absence of actin follows a
single exponential with a rate of 1.5 s
1 in KMg0 and
KMg50 (Fig. 7A). There is no lag in the phosphate release
transients (Fig. 7A, inset), indicating that
phosphate release precedes ADP release. Unlike previously characterized myosins (28, 30), actin did not increase the rate of phosphate release
(Fig 7B). This result is likely caused by the weak affinity of the M·ADP·Pi state for actin (see
"Discussion").
ADP Association and Dissociation--
The fluorescence increase of
mantADP was used to determine the rate constants for ADP association to
myo1eIQ and actomyo1eIQ (Fig.
8). In the absence of actin, time courses
of fluorescence fit two exponential rates with approximately equal
amplitudes. The fast phase was hyperbolically related to the nucleotide
concentration (Fig. 8A) and modeled as a two-step binding
reaction,

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 8.
Kinetics of mantADP binding to
myo1eIQ. A, rate of mantADP binding to 0.5 µM myo1eIQ as a function of nucleotide
concentration measured using fluorescence resonance energy transfer.
The observed rates (kobs) were obtained by
fitting the stopped flow fluorescence transients at each nucleotide
concentration to the sum of two exponentials. The solid line
is the best fit of the fast kobs ( ) to a
rectangular hyperbola. The inset shows the nucleotide
concentration dependence of the slow kobs ( ).
B, fluorescence transient showing the time course of mantADP
dissociation from myo1eIQ. An equilibrated mixture of 10 µM mantADP and 0.6 µM myo1eIQ
was mixed with 2.5 mM ATP. The smooth line shows
the best fit of the data to the sum of two exponentials.
|
|
where * indicates high mantADP fluorescence. The maximum
rate is k
5 = 237 ± 13 s
1
and K6 = 6.0 ± 0.9 µM (Table
II). The rate of the slow exponential phase shows only a slight
nucleotide dependence and plateaus at ~11 s
1 at >10
µM mantADP (Fig. 8A, inset). The
origin of this second exponential is not known, but it may report the
population of a second M·ADP state (see "Discussion").
In the presence of actin, time courses of fluorescence were best fit to
single exponential rates that were linearly related to the nucleotide
concentration (Fig. 9A). The
signal to noise ratio of the fluorescence signal limited the range of
testable mantADP concentrations, so we were not able to measure the
maximum rate of mantADP binding (k
5').
Therefore, the apparent second order rate constant for mantADP binding
was obtained by a linear fit to the data assuming the two-step binding
model of Reaction 5 (k
5'/K6' = 13 ± 1.8 µM
1 s
1; Fig.
9A). The non-zero y intercept reveals a
dissociation rate constant of k+5' = 93 ± 5 s
1.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 9.
Kinetics of mantADP binding to
actomyo1eIQ. A, rate of mantADP binding to
0.5 µM actomyo1eIQ as a function of
nucleotide concentration. The observed rates
(kobs) were obtained by fitting the stopped flow
fluorescence data to a single exponential. The solid line is
the best linear fit of kobs. The fluorescence
transient in the inset shows the dissociation of mantADP
from actomyo1eIQ obtained by mixing 2.5 mM ATP
with an equilibrated mixture of 10 µM mantADP and 0.5 µM actomyo1eIQ. The smooth line is
a single exponential fit to the data. B, dependence on the
rate of 80 µM ATP binding to
pyrene-actomyo1eIQ on the concentration of ADP. The
observed rate (kobs) at each ADP concentration
was obtained by fitting the fluorescent transient to a single
exponential. The solid line is the best fit of the data to a
hyperbola as described in Equation 1.
|
|
The rates of mantADP dissociation from myo1eIQ (Fig.
8B) and actomyo1eIQ (Fig. 9A,
inset) were measured by competition with 250-fold excess of
MgATP. Fluorescence time courses of mantADP dissociation fit two-exponential rates of 6.3 and 1.7 s
1 in the absence of
actin and a single exponential rate of k+5' = 104 ± 4 s
1 in the presence of actin (Table II). The
rate of MgADP dissociation from actomyo1eIQ is similar to
that reported by the y intercept in the mantADP association
experiment (Fig. 9A).
The affinity of MgADP for actomyo1eIQ was
determined by competition experiments in which the ternary
pyrene-actomyo1eIQ-ADP complex was mixed with MgATP (Fig.
9B). Fluorescence transients fit single exponential rates
that had a hyperbolic dependence on the MgADP concentration, suggesting
that AM·D and AM states are in rapid equilibrium. Therefore, the
dependence of kobs on MgADP concentration is as
follows,
|
(Eq. 1)
|
where kobs is the observed dissociation
rate, k0 is the dissociation rate in the absence
of ADP (K1'k2'[ATP];
Table II), and Kd is the dissociation
equilibrium constant for ADP
(K5'K6'). Nonlinear least
square fits to the data yielded a dissociation equilibrium constant of
K5'K6' = 3.9 ± 0.29 µM (Table II), which is similar to the calculated value
(K5'K6' = 8 µM) using association and dissociation rate of mantADP.
 |
DISCUSSION |
Overview of the Myo1eIQ
ATPase--
Myo1eIQ has a high basal ATPase rate
(vo; Table I), yet all measured rate constant
are >2-fold faster than v0 (Table II), so we
cannot assign a single step as rate-limiting. The slower turnover number is the result of two sequential steps (phosphate release and ADP
release) with nearly equivalent rates. Kinetic modeling of the ATPase
reaction using our determined rate constants (Table II) yields an
ATPase rate (v0 = 0.65 s
1 in
KMg50), which is similar to the experimentally determined value
(v0 = 0.58 ± 0.04 s
1; Table
I). The predominant steady-state intermediates in the absence of actin
are M·ADP·Pi and M·ADP (Scheme 1).
Overview of the Actomyo1eIQ
ATPase--
Myo1eIQ has a low
KATPase and has a ~2-fold actin activation of
its ATPase rate (Table I), which is similar to that found for the
native molecule. Actin (0-40 µM) does not increase the
rate of Pi release in KMg0 or KMg50 (Fig. 7B).
Therefore, actin activation of Pi release is not the
mechanism for actin activation of the ATPase rate, as it is for other
myosins. Rather, the increased ATPase rate is the result of actin
activation of ADP release. The predominant pathway under actin
concentrations used in our assays is one in which (a) ATP
binding, actin dissociation, and ATP hydrolysis are fast and not
rate-limiting; (b) Pi is released while myosin
is detached from actin; (c) M·ADP binds to actin; and
(d) ADP is released from actin-bound myosin (Fig.
10A, outlined pathway). The rate-limiting step at saturating actin
(Vmax) is defined by the rate of Pi
release (k+4), because at saturating actin ADP
release is ~100 s
1 (Table II). The
KATPase value is related to the affinity of the M·ADP state for actin. Because binding measurements indicate that myo1eIQ binds weakly to actin in the presence of ATP (Fig.
2), the predominant steady-state intermediate is an actin-detached
M·ADP·Pi state.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 10.
Models for myo1e function.
A, the predominant ATPase pathway of myo1eIQ
under in vitro assay conditions is outlined. We
propose that under cellular conditions, native myo1e follows the
pathway proposed by Lymn and Taylor (43; gray shading).
B, comparison of the loop-2 regions of myosins isoforms.
Basic amino acids are boxed, and the conserved KK regions
shown to be necessary for actin activation of Pi are
underlined. Numbers identify the sequence
positions. SmII, smooth muscle myosin-II; SkII,
skeletal muscle myosin-II; DdII, Dictyostelium
myosin-II; AcMIC, Acanthamoeba myosin-IC.
|
|
ATP Binding and Actomyo1eIQ Dissociation--
The
binding of ATP to myo1eIQ and actomyo1eIQ, as
determined by dmantATP fluorescence, is fast. The rate of binding at
physiological nucleotide concentrations is >100-fold faster than the
rate-limiting step(s). Therefore, the nucleotide-free state of
myo1eIQ is not significantly populated. The rate of
population of the weak binding states as measured by pyrene-actin
fluorescence and light scattering is also fast, and ATP-induced
dissociation from actin is limited only by the rate of ATP binding.
The rate of ATP binding to actomyo1eIQ as measured by mant
fluorescence is ~4-fold faster than the rate measured by pyrene-actin fluorescence or light scattering. Additionally, the linear fit of the
rates of dmantATP binding to actomyo1eIQ does not pass
through the origin (Fig. 4B) but gives a y
intercept of 25 s
1. The value of the y
intercept likely reports a reverse isomerization rate
(k
2') of myo1eIQ. However, because
the rate of ATP-induced dissociation of actomyo1eIQ is
>400 s
1 (Fig. 5) and essentially irreversible under the
low actin concentration conditions of the experiment, a relatively slow
reverse isomerization of the ATP binding step should not be observable.
Therefore, the faster rate of mantATP binding and the observed reversal
rate (k
2') are likely the result of an
artifact because of the fluorescent modification of the 3' position of
ATP. Although the dmantATP experiments probably do not report the true
rate constants for ATP binding in the presence of actin, the
experiments do reveal differences in the structural isomerization
required for tight ATP binding in the presence and absence of actin.
Additionally, because similar mant artifacts are not seen with other
characterized myosins (e.g. 14), the experiments show that
there are significant structural differences at the nucleotide binding
sites of myosin-I isoforms.
Phosphate Release--
The v0 and
Vmax rates and the extent of actin activation of
myo1eIQ (Table I) are similar to the values measured for
native myo1e purified from rat liver (19), so the biochemical rate and
equilibrium constants determined for Sf9-expressed
myo1eIQ are likely identical to the native molecule.
Therefore, the fast rate of Pi release
(k+4) is not an artifact of the expression system or of the expression of a truncated protein.
The rate of phosphate release from all previously characterized myosins
is increased by actin binding (28, 30, 35). However, we did not detect
actin activation of phosphate release from myo1eIQ. We
propose that the lack of actin activation is caused by the low affinity
of the M·ADP·Pi state for actin. Other myosins bind actin in the presence of ATP with equilibrium dissociation constants <50 µM at low ionic strength conditions (36, 37),
whereas myo1eIQ clearly binds with a dissociation
constant > 50 µM (Fig. 2). The ionic component of
actin binding has been shown to be mediated by positive charges in
surface loop-2 of myosin (36). Loop-2 of myo1e is shorter than those
found in other characterized myosins (Fig. 10B) and does not
contain the positively charged amino acids in the region that has been
shown to be required for actin binding (Fig. 10B (36)).
However, loop-2 of myo1e contains the KK region (Fig. 10B,
underlined) shown to be crucial for actin activation of
phosphate release (37). Therefore, it is possible that actin activates
phosphate release from myo1eIQ, but we are not able to
achieve high enough actin concentrations to populate the weakly bound
AM·ADP·Pi state. Weak actin binding may be a kinetic
adaptation required for cellular function (see below).
It is possible that phosphate release by myo1eIQ is
uncoupled from actin binding, so the very high basal rate of
Pi release (k+4) is also the rate
when myo1eIQ is attached to actin
(k+4'). Why myo1e would evolve a mechanism that
seemingly wastes ATP is not clear; however, other mechanisms for the
suppression of the basal ATPase rate may exist. For example, the tail
domain (which is not present in myo1eIQ) is thought to
regulate the ATPase activity of myo1e allosterically (19). Further
experiments are required to determine whether the myo1e tail regulates
phosphate release directly.
ADP Binding and Release--
Time courses of mantADP binding to
myo1eIQ are best fit to two exponentials. The rate of the
fast phase is hyperbolically related to the nucleotide concentration as
expected for a two-step binding reaction (Reaction 6). The rate of the
slow exponential does not show a significant nucleotide dependence and
possibly reports the population of a second higher fluorescence state
M·ADP state,
where * indicates the fluorescence state of myosin,
k
5a is the maximum rate of the fast phase, and
k
5b is the maximum rate of the slow
fluorescence change. It has been shown previously that myosins exists
in more than one ADP state (14, 38), so it is not surprising that we
are able to detect multiple conformations of myo1eIQ.
Dissociation of mantADP in the absence of actin also shows two exponentials that are likely related to these two states. However, a
more detailed analysis of ADP binding is required to characterize these
states better.
The similarity of the rates of Pi release and ADP release
in the absence of actin raises the possibility that the products are
released simultaneously (Table II). However, if ADP and Pi were released together, steady-state measurements of
v0 would be >2-fold faster (see above).
Time courses of mantADP binding to actomyo1eIQ fit single
exponentials that are linearly related to the nucleotide concentration (Fig. 9A). A linear fit to the data does not pass through
the origin but reveals a dissociation rate
(k+5') of ~100 s
1. This
dissociation rate is nearly identical to the dissociation rate
determined directly by displacing myo1eIQ-bound mantADP
with unlabeled ATP (Fig. 9A, inset). The
dissociation equilibrium constant
(K5'K6') calculated by
dividing the dissociation rate (k+5') by the
association rate
(k
5'/K6') obtained from
the mantADP experiments is within a factor of 2 of that determined from
the pyrene-actin fluorescence experiments. Therefore, it is unlikely
that the mantADP experiments are reporting artifactually high rates as
shown for dmantATP binding to actin (see above).
Comparison with Other Myosin-I--
Myo1e is the first vertebrate
subclass-1 myosin-I to be characterized. Like the subclass-1 isoforms
from Acanthamoeba (13), myo1e has relatively large rate
constants that are similar to those of skeletal muscle myosin-II (Table
II). Most notably, the rates of ADP release from all subclass-1
isoforms are >10-fold faster than subclass-2 isoforms, i.e.
the lifetimes of the AM·ADP states are >10 longer for subclass-2
isoforms (13-16). The rate of ADP release limits sliding velocity
(39), so we propose that subclass-1 isoforms are better tuned for fast
motility, whereas subclass-2 isoforms are better tuned for maintenance
of force (14, 15).
A difference among the amoeba and vertebrate subclass-1 isoforms is
that Acanthamoeba myosin-IA and -IB have low basal ATPase rates (<0.1 s
1) and a large actin activation of the
steady-state ATPase (> 50-fold (40)), whereas myo1e has an high basal
ATPase rate and a low actin activation (Table I). Like myo1e,
vertebrate subclass-2 isoforms also have high basal ATPase rates and
relatively low actin activations (41). This might be an adaptation to
the cellular environment of vertebrate cells, or it might be related to
the regulation of myosin-I in these cells (8). A second difference between amoeba subclass-1 isoforms and myo1e is, like subclass-2 isoforms, myo1e has a very high ADP affinity
(K5'K6' < 10 µM). Therefore, it is possible that ADP release from both
vertebrate subclasses is highly force-dependent (14,
15).
Relevance of Myo1e Kinetics to in Vivo Function--
Like all
other characterized myosin-I isoforms (13-16), myo1e is a low duty
ratio motor, so under unloaded conditions it is predominantly weakly
bound or detached from actin filaments. Therefore, for myole to support
motility, a high effective duty ratio must be created by bringing
together locally high concentrations of myosin and actin. Such a
mechanism is consistent with its observed cellular localization in
regions of high F-actin concentration (17, 18).
The force-generating power stroke of myosin is thought to accompany
phosphate release (42). Therefore, an ATPase pathway in which phosphate
is released while myosin is detached from the actin filament (Fig.
10A, outlined pathway) would not generate force.
It is possible that the power stroke occurs at a different step in the
myo1e ATPase pathway (e.g. ADP release); however, this
possibility is unlikely given the sequence and mechanistic conservation
among myosin isoforms. We propose that the low actin affinity of myo1e
in the presence of ATP is an adaptation to the high actin concentration
environment in which myo1e functions (17, 18). Native myo1e cross-links
actin filaments via an ATP-insensitive actin binding site in its tail,
creating densely packed and cross-linked bundles (19). If the weak
binding states (M·ATP and M·ADP·Pi) of myo1e had a
high actin affinity, then ATP hydrolysis and the recovery stroke
would occur while attached to actin (30). Therefore, an associated
hydrolysis pathway would result in the reversal of myosin's power
stroke. To ensure that myo1e is detached from actin during the recovery
stroke, a weak affinity must be maintained in the pre-force-generating
states. We therefore predict that under the high actin concentrations of the cell, the M·ADP·Pi state will bind and release
phosphate while attached to actin (Fig. 10A, gray
pathway) as proposed for other myosins (43). Further experiments are
required to confirm this prediction and to understand better the unique
kinetic adaptations of all vertebrate myosin-I isoforms.
 |
ACKNOWLEDGEMENTS |
We thank Tianming Lin and Jade Poole for
technical assistance; Li-Qiong Chen for constructing the expression
virus; William M. Bement for providing the myo1e cDNA; and H. Lee
Sweeney, Yale E. Goldman, and Enrique M. De La Cruz for helpful
discussions and comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by National
Institutes of Health Grant GM57247 and an American Heart Association
Grant (to E. M. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a Wellcome Trust Research career development fellowship.
To whom correspondence should be addressed: Dept. of
Physiology, B400 Richards, University of Pennsylvania School of
Medicine, 3700 Hamilton Walk, Philadelphia, PA 19104-6085. Tel.:
215-573-9758; Fax: 215-573-1171; E-mail:
ostap@mail.med.upenn.edu.
Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M200713200
 |
ABBREVIATIONS |
The abbreviations used are:
mant, N-methyanthraniloyl;
A, actin;
CaM, calmodulin;
dmant, 2'-deoxymant;
DTT, dithiothreitol;
M, myosin;
PiBP, phosphate-binding protein;
pyrene-actin, pyrenyl
iodoacetamide-labeled actin.
 |
REFERENCES |
| 1.
|
Berg, J. S.,
Powell, B. C.,
and Cheney, R. E.
(2001)
Mol. Biol. Cell
12,
780-794[Abstract/Free Full Text]
|
| 2.
|
Dai, J.,
Ting-Beall, H. P.,
Hochmuth, R. M.,
Sheetz, M. P.,
and Titus, M. A.
(1999)
Biophys. J.
77,
1168-1176[Abstract/Free Full Text]
|
| 3.
|
Geli, M. I.,
and Riezman, H.
(1996)
Science
272,
533-535[Abstract]
|
| 4.
|
Jung, G., Wu, X.,
and Hammer, J. A., III
(1996)
J. Cell Biol.
133,
305-323[Abstract/Free Full Text]
|
| 5.
|
Raposo, G.,
Cordonnier, M. N.,
Tenza, D.,
Menichi, B.,
Durrbach, A.,
Louvard, D.,
and Coudrier, E.
(1999)
Mol. Biol. Cell.
10,
1477-1494[Abstract/Free Full Text]
|
| 6.
|
Novak, K. D.,
Peterson, M. D.,
Reedy, M. C.,
and Titus, M. A.
(1995)
J. Cell Biol.
131,
1205-1221[Abstract/Free Full Text]
|
| 7.
|
Gillespie, P. G.,
Wagner, M. C.,
and Hudspeth, A. J.
(1993)
Neuron
11,
581-594[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Tang, N.,
and Ostap, E. M.
(2001)
Curr. Biol.
11,
1131-1135[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Sokac, A. M.,
and Bement, W. M.
(2000)
Int. Rev. Cytol.
200,
197-304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Pollard, T. D.,
and Korn, E. D.
(1973)
J. Biol. Chem.
248,
4682-4690[Abstract/Free Full Text]
|
| 11.
|
Bement, W. M.,
Wirth, J. A.,
and Mooseker, M. S.
(1994)
J. Mol. Biol.
243,
356-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Stöffler, H.-E.,
Ruppert, C.,
Reinhard, J.,
and Bähler, M.
(1995)
J. Cell Biol.
129,
819-830[Abstract/Free Full Text]
|
| 13.
|
Ostap, E. M.,
and Pollard, T. D.
(1996)
J. Cell Biol.
32,
1053-1060
|
| 14.
|
Jontes, J. D.,
Milligan, R. A.,
Pollard, T. D.,
and Ostap, E. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14332-14337[Abstract/Free Full Text]
|
| 15.
|
Coluccio, L. M.,
and Geeves, M. A.
(1999)
J. Biol. Chem.
274,
21575-21580[Abstract/Free Full Text]
|
| 16.
|
Geeves, M. A.,
Perreault-Micale, C.,
and Coluccio, L. M.
(2000)
J. Biol. Chem.
275,
21624-21630[Abstract/Free Full Text]
|
| 17.
|
Stöffler, H.-E.,
Honnert, U.,
Bauer, C. A.,
Hofer, D.,
Schwarz, H.,
Muller, R. T.,
Drenckhahn, D.,
and Bähler, M.
(1998)
J. Cell Sci.
111,
2779-2788[Abstract]
|
| 18.
|
Skowron, J. F.,
Bement, W. M.,
and Mooseker, M. S.
(1998)
Cell Motil. Cytoskeleton
41,
308-324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Stöffler, H.-E.,
and Bähler, M.
(1998)
J. Biol. Chem.
273,
14605-14611[Abstract/Free Full Text]
|
| 20.
|
Bement, W. M.,
and Mooseker, M. S.
(1995)
Cell Motil. Cytoskeleton
31,
87-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Hiratsuka, T.
(1983)
Biochim. Biophys. Acta
742,
496-508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Spudich, J. A.,
and Watt, S.
(1971)
J. Biol. Chem.
246,
4866-4871[Abstract/Free Full Text]
|
| 23.
|
Houk, T. W.,
and Ue, K.
(1974)
Anal. Biochem.
62,
66-74[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Pollard, T. D.
(1984)
J. Cell Biol.
99,
769-777[Abstract/Free Full Text]
|
| 25.
|
Putkey, J. A.,
Slaughter, G. R.,
and Means, A. R.
(1985)
J. Biol. Chem.
260,
4704-4712[Abstract/Free Full Text]
|
| 26.
|
De La Cruz, E. M.,
Wells, A. L.,
Rosenfeld, S. S.,
Ostap, E. M.,
and Sweeney, H. L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13726-13731[Abstract/Free Full Text]
|
| 27.
|
De La Cruz, E. M.,
Sweeney, H. L.,
and Ostap, E. M.
(2000)
Biophys. J.
79,
1524-1529[Abstract/Free Full Text]
|
| 28.
|
De La Cruz, E. M.,
Wells, A. L.,
Sweeney, H. L.,
and Ostap, E. M.
(2000)
Biochemistry
39,
14196-14202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Chalovich, J. M.,
and Eisenberg, E.
(1982)
J. Biol. Chem.
257,
2432-2437[Free Full Text]
|
| 30.
|
White, H. D.,
Belknap, B.,
and Webb, M. R.
(1997)
Biochemistry
30,
11828-11836
|
| 31.
|
Xing, J.,
Wriggers, W.,
Jefferson, G. M.,
Stein, R.,
Cheung, H. C.,
and Rosenfeld, S. S.
(2000)
J. Biol. Chem.
275,
35413-35423[Abstract/Free Full Text]
|
| 32.
|
Johnson, K. A.,
and Taylor, E. W.
(1978)
Biochemistry
17,
3432-3442[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Woodward, S. K. A.,
Eccleston, J. F.,
and Geeves, M. A.
(1991)
Biochemistry
30,
422-430[CrossRef][Medline]
|